3 ms·
So, I can't get to your site, but this seems a little disingenuous as a title. You're not seemingly "unlocking" anything more than a protocol for Sanger sequenc
by lvs 7y ago
So, I can't get to your site, but this seems a little disingenuous as a title. You're not seemingly "unlocking" anything more than a protocol for Sanger sequencing that, if it eventually was approved and actually tested against real samples and people elsewhere adapted the protocols to use for testing, you would then... at that point... unlock a thing.
- dang 7y agoSince people seem to be reacting to the word "unlocking" in the title, I've replaced it with "working on".
- lvs 7y agoThanks. Make him explain whether the machine learning is real too, since his linked manuscript doesn't say anything about it. This is a really exploitative moment to be hyping things.
- dang 7y agoIt looks like David answered that here: https://news.ycombinator.com/item?id=22808525 https://news.ycombinator.com/item?id=22808525. I agree that it's better not to use buzzwords, and have edited the top text to say "linear regression" instead of "machine learning". (This is actually part of the standard advice we give to YC startups who are launching on HN: don't talk like you would to investors—talk as you do to fellow implementors.)
- billiontoone 7y agoBoth the methods and David's twitter clearly describe the linear regression as the method and how it works with spike-in. In practice, it is a lot more complicated, as the signal-to-noise ratio can interfere with the regression and primer N-1 synthesis errors need to be accounted for. That is why we are willing to help other laboratories with our bioinformatics pipeline.